Epigenetics in extracellular matrix remodeling and hyaluronan metabolism

FEBS Journal

Volumn 281, Issue 22, 2014, Pages 4980-4992

  Vigetti, Davide ^a   Viola, Manuela ^a   Karousou, Evgenia ^a   Deleonibus, Sara ^a   Karamanou, Konstantina ^b   De Luca, Giancarlo ^a   Passi, Alberto ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

cell microenvironment; glycosaminoglycans; histone modifications; matrix metalloproteinases; mRNA; natural antisense transcript; O GlcNAcylation; proteoglycans; sirtuin

Indexed keywords

GLUCURONOSYLTRANSFERASE; HAS2 PROTEIN, HUMAN; HISTONE; HYALURONIC ACID; MICRORNA;

ANIMAL; DIABETES MELLITUS; EXTRACELLULAR MATRIX; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; DIABETES MELLITUS; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; GLUCURONOSYLTRANSFERASE; HISTONES; HUMANS; HYALURONIC ACID; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84910124848     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12938     Document Type: Review

References (128)

1. Vigetti D, Gotte M, Pavao MS, &, Theocharis AD, (2013) Cellular microenvironment in human pathologies. BioMed Res Int 2013, 946958.
2. Xiong A, Kundu S, &, Forsberg-Nilsson K, (2014) Heparan sulfate in the regulation of neural differentiation and glioma development. FEBS J 281, 4993-5008.
3. Ibrahim SA, Hassan H, &, Götte M, (2014) MicroRNA regulation of proteoglycan function in cancer. FEBS J 281, 5009-5022.
4. Theocharis AD, Gialeli C, Bouris P, Giannopoulou E, Skandalis SS, Aletras AJ, Iozzo RV, &, Karamanos NK, (2014) Cell-matrix interactions: Focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. FEBS J 281, 5023-5042.
5. Reference withdrawn.
6. Heard E, &, Martienssen RA, (2014) Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157, 95-109.
7. Kouzarides T, (2007) Chromatin modifications and their function. Cell 128, 693-705.
8. Hanover JA, Krause MW, &, Love DC, (2012) Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 13, 312-321.
9. Munshi A, Shafi G, Aliya N, &, Jyothy A, (2009) Histone modifications dictate specific biological readouts. J Genet Genomics 36, 75-88.
10. Lee KK, &, Workman JL, (2007) Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol 8, 284-295.
11. Li B, Carey M, &, Workman JL, (2007) The role of chromatin during transcription. Cell 128, 707-719.
12. Adcock IM, Tsaprouni L, Bhavsar P, &, Ito K, (2007) Epigenetic regulation of airway inflammation. Curr Opin Immunol 19, 694-700.
13. Jenuwein T, &, Allis CD, (2001) Translating the histone code. Science 293, 1074-1080.
14. Rice JC, &, Allis CD, (2001) Code of silence. Nature 414, 258-261.
15. Bannister AJ, &, Kouzarides T, (2005) Reversing histone methylation. Nature 436, 1103-1106.
16. Gosden RG, &, Feinberg AP, (2007) Genetics and epigenetics-nature's pen-and-pencil set. N Engl J Med 356, 731-733.
17. Lokeshwar VB, Gomez P, Kramer M, Knapp J, McCornack MA, Lopez LE, Fregien N, Dhir N, Scherer S, Klumpp DJ, et al,. (2008) Epigenetic regulation of HYAL-1 hyaluronidase expression. Identification of HYAL-1 promoter. J Biol Chem 283, 29215-29227.
18. Hou H, &, Yu H, (2010) Structural insights into histone lysine demethylation. Curr Opin Struct Biol 20, 739-748.
19. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, &, El-Osta A, (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229-1236.
20. Zhong Q, &, Kowluru RA, (2013) Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62, 2559-2568.
21. Rekowski M, &, Giannis A, (2010) Histone acetylation modulation by small molecules: A chemical approach. Biochim Biophys Acta 1799, 760-767.
22. Jones PA, &, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428.
23. Kurdistani SK, &, Grunstein M, (2003) Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 4, 276-284.
24. Polevoda B, &, Sherman F, (2002) The diversity of acetylated proteins. Genome Biol 3, reviews0006.
25. Roth SY, Denu JM, &, Allis CD, (2001) Histone acetyltransferases. Annu Rev Biochem 70, 81-120.
26. Egger G, Liang G, Aparicio A, &, Jones PA, (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463.
27. Adcock IM, Ford P, Ito K, &, Barnes PJ, (2006) Epigenetics and airways disease. Respir Res 7, 21.
28. Perkins ND, (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717-6730.
29. Adcock IM, (2007) HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 150, 829-831.
30. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, et al,. (2010) Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327, 1004-1007.
31. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, et al,. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.
32. Baur JA, Ungvari Z, Minor RK, Le Couteur DG, &, de Cabo R, (2012) Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 11, 443-461.
33. Mitchell SJ, Martin-Montalvo A, Mercken EM, Palacios HH, Ward TM, Abulwerdi G, Minor RK, Vlasuk GP, Ellis JL, Sinclair DA, et al,. (2014) The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep 6, 836-843.
34. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V, &, Seluanov A, (2013) High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499, 346-349.
35. Lockwood WW, Zejnullahu K, Bradner JE, &, Varmus H, (2012) Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci USA 109, 19408-19413.
36. Sakabe K, Wang Z, &, Hart GW, (2010) β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A 107, 19915-19920.
37. Thorne JL, Campbell MJ, &, Turner BM, (2009) Transcription factors, chromatin and cancer. Int J Biochem Cell Biol 41, 164-175.
38. Vaquero A, &, Reinberg D, (2009) Calorie restriction and the exercise of chromatin. Genes Dev 23, 1849-1869.
39. Marshall S, Bacote V, &, Traxinger RR, (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266, 4706-4712.
40. Hanover JA, (2010) Epigenetics gets sweeter: O-GlcNAc joins the 'histone code'. Chem Biol 17, 1272-1274.
41. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, &, Winberg JO, (2011) Regulation of matrix metalloproteinase activity in health and disease. FEBS J 278, 28-45.
42. Passi A, Negrini D, Albertini R, Miserocchi G, &, De Luca G, (1999) The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett 456, 93-96.
43. Chernov AV, Sounni NE, Remacle AG, &, Strongin AY, (2009) Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J Biol Chem 284, 12727-12734.
44. Farias LC, Gomes CC, Rodrigues MC, de Castro WH, Lacerda JC, Ferreira EF, &, Gomez RS, (2012) Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma. BMC Clin Pathol 12, 11.
45. Qin L, &, Han YP, (2010) Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: Implication in tissue fibrosis. Am J Pathol 177, 1915-1928.
46. Bartel DP, (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233.
47. Bourguignon LY, (2012) Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Small GTPases 3, 53-59.
48. Sayed D, &, Abdellatif M, (2011) MicroRNAs in development and disease. Physiol Rev 91, 827-887.
49. Cullen BR, (2004) Derivation and function of small interfering RNAs and microRNAs. Virus Res 102, 3-9.
50. Wentz-Hunter KK, &, Potashkin JA, (2011) The role of miRNAs as key regulators in the neoplastic microenvironment. Mol Biol Int 2011, 839872.
51. Chen L, &, Bourguignon LY, (2014) Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells. Mol Cancer 13, 52.
52. Bourguignon LY, Xia W, &, Wong G, (2009) Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates β-catenin signaling and NFκB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 284, 2657-2671.
53. Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX, Liu Y, Cheang TY, Huang XL, &, Wang SM, (2011) MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 31, 2044-2053.
54. Stein JJ, Iwuchukwu C, Maier KG, &, Gahtan V, (2014) Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. Surgery 155, 228-233.
55. Midgley AC, Bowen T, Phillips AO, &, Steadman R, (2014) MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts. Aging Cell 13, 235-244.
56. Lagendijk AK, Goumans MJ, Burkhard SB, &, Bakkers J, (2011) MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ Res 109, 649-657.
57. Yang X, Rutnam ZJ, Jiao C, Wei D, Xie Y, Du J, Zhong L, &, Yang BB, (2012) An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle 11, 3097-3108.
58. Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR, Banerjee S, &, Schmittgen TD, (2010) miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 403, 120-125.
59. Stern R, (2007) Complicated hyaluronan patterns in skin: Enlightenment by UVB? J Invest Dermatol 127, 512-513.
60. Bourguignon LY, Wong G, Xia W, Man MQ, Holleran WM, &, Elias PM, (2013) Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction. J Dermatol Sci 72, 32-44.
61. Mancini M, Lena AM, Saintigny G, Mahe C, Di Daniele N, Melino G, &, Candi E, (2014) MicroRNAs in human skin ageing. Ageing Res Rev doi: 10.1016/j.arr.2014.04.003.
62. Tammi R, Paukkonen K, Wang C, Horsmanheimo M, &, Tammi M, (1994) Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces. Arch Dermatol Res 286, 21-29.
63. Zibert JR, Lovendorf MB, Litman T, Olsen J, Kaczkowski B, &, Skov L, (2010) MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 58, 177-185.
64. Wight TN, Kinsella MG, Evanko SP, Potter-Perigo S, &, Merrilees MJ, (2014) Versican and the regulation of cell phenotype in disease. Biochim Biophys Acta 1840, 2441-2451.
65. Rutnam ZJ, Wight TN, &, Yang BB, (2013) miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol 32, 74-85.
66. Michael DR, Phillips AO, Krupa A, Martin J, Redman JE, Altaher A, Neville RD, Webber J, Kim MY, &, Bowen T, (2011) The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. J Biol Chem 286, 19523-19532.
67. Rinn JL, &, Chang HY, (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81, 145-166.
68. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, et al,. (2012) The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res 22, 1775-1789.
69. Batista PJ, &, Chang HY, (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298-1307.
70. Kjellen L, &, Lindahl U, (1991) Proteoglycans: Structures and interactions. Annu Rev Biochem 60, 443-475.
71. Gandhi NS, &, Mancera RL, (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72, 455-482.
72. Jiang D, Liang J, &, Noble PW, (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91, 221-264.
73. Jiang D, Liang J, &, Noble PW, (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23, 435-461.
74. Toole BP, (2001) Hyaluronan in morphogenesis. Semin Cell Dev Biol 12, 79-87.
75. Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, &, Ghatak S, (2011) Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J 278, 1429-1443.
76. Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen P, &, Tammi MI, (2008) Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 18, 288-295.
77. Toole BP, Wight TN, &, Tammi MI, (2002) Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277, 4593-4596.
78. Laurent TC, &, Fraser JR, (1992) Hyaluronan. FASEB J 6, 2397-2404.
79. Vigetti D, Karousou E, Viola M, Deleonibus S, De Luca G, &, Passi A, (2014) Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta 840, 2452-2459.
80. Vigetti D, Rizzi M, Moretto P, Deleonibus S, Dreyfuss JM, Karousou E, Viola M, Clerici M, Hascall VC, Ramoni MF, et al,. (2011) Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells. J Biol Chem 286, 34497-34503.
81. Stern R, Asari AA, &, Sugahara KN, (2006) Hyaluronan fragments: An information-rich system. Eur J Cell Biol 85, 699-715.
82. Powell JD, &, Horton MR, (2005) Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res 31, 207-218.
83. Weigel PH, &, DeAngelis PL, (2007) Hyaluronan synthases: A decade-plus of novel glycosyltransferases. J Biol Chem 282, 36777-36781.
84. Hubbard C, McNamara JT, Azumaya C, Patel MS, &, Zimmer J, (2012) The hyaluronan synthase catalyzes the synthesis and membrane translocation of hyaluronan. J Mol Biol 418, 21-31.
85. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, et al,. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274, 25085-25092.
86. Rilla K, Oikari S, Jokela TA, Hyttinen JM, Karna R, Tammi RH, &, Tammi MI, (2013) Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. J Biol Chem 288, 5973-5983.
87. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, &, McDonald JA, (2002) Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 8, 850-855.
88. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, &, McDonald JA, (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106, 349-360.
89. Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, &, Tammi MI, (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278, 1419-1428.
90. Jacobson A, Brinck J, Briskin MJ, Spicer AP, &, Heldin P, (2000) Expression of human hyaluronan synthases in response to external stimuli. Biochem J 348, 29-35.
91. Vigetti D, Genasetti A, Karousou E, Viola M, Moretto P, Clerici M, Deleonibus S, De Luca G, Hascall VC, &, Passi A, (2010) Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-κB (NF-κB) pathway. J Biol Chem 285, 24639-24645.
92. Stern R, Shuster S, Neudecker BA, &, Formby B, (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited. Exp Cell Res 276, 24-31.
93. Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall VC, Tammi M, De Luca G, &, Passi A, (2012) Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem 287, 35544-35555.
94. Sainio A, Jokela T, Tammi MI, &, Jarvelainen H, (2010) Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis. Glycobiology 20, 1117-1126.
95. Viola M, Bartolini B, Vigetti D, Karousou E, Moretto P, Deleonibus S, Sawamura T, Wight TN, Hascall VC, De Luca G, et al,. (2013) Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells. J Biol Chem 288, 29595-29603.
96. Stern R, (2004) Hyaluronan catabolism: A new metabolic pathway. Eur J Cell Biol 83, 317-325.
97. Soltes L, Stankovska M, Kogan G, Gemeiner P, &, Stern R, (2005) Contribution of oxidative-reductive reactions to high-molecular-weight hyaluronan catabolism. Chem Biodivers 2, 1242-1245.
98. Jing W, &, DeAngelis PL, (2004) Synchronized chemoenzymatic synthesis of monodisperse hyaluronan polymers. J Biol Chem 279, 42345-42349.
99. DeAngelis PL, (2008) Monodisperse hyaluronan polymers: Synthesis and potential applications. Curr Pharm Biotechnol 9, 246-248.
100. Vigetti D, Ori M, Viola M, Genasetti A, Karousou E, Rizzi M, Pallotti F, Nardi I, Hascall VC, De Luca G, et al,. (2006) Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J Biol Chem 281, 8254-8263.
101. Buse MG, (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290, E1-E8.
102. Hascall VC, Wang A, Tammi M, Oikari S, Tammi R, Passi A, Vigetti D, Hanson RW, &, Hart GW, (2014) The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol 35, 14-17.
103. Wang A, &, Hascall VC, (2004) Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 279, 10279-10285.
104. Vigetti D, Viola M, Karousou E, De Luca G, &, Passi A, (2014) Metabolic control of hyaluronan synthases. Matrix Biol 35, 8-13.
105. Hardie DG, (2004) The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117, 5479-5487.
106. Russo GL, Russo M, &, Ungaro P, (2013) AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem Pharmacol 86, 339-350.
107. Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, Moretto P, Heldin P, Hascall VC, De Luca G, &, Passi A, (2011) Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem 286, 7917-7924.
108. Doran AC, Meller N, &, McNamara CA, (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28, 812-819.
109. Bourguignon LY, Gilad E, &, Peyrollier K, (2007) Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem 282, 19426-19441.
110. Karousou E, Kamiryo M, Skandalis SS, Ruusala A, Asteriou T, Passi A, Yamashita H, Hellman U, Heldin CH, &, Heldin P, (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem 285, 23647-23654.
111. Evanko SP, &, Wight TN, (1999) Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem 47, 1331-1342.
112. Knudson W, Chow G, &, Knudson CB, (2002) CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 21, 15-23.
113. Vigetti D, Genasetti A, Karousou E, Viola M, Clerici M, Bartolini B, Moretto P, De Luca G, Hascall VC, &, Passi A, (2009) Modulation of hyaluronan synthase activity in cellular membrane fractions. J Biol Chem 284, 30684-30694.
114. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, &, Strong SA, (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid. Inter-α-trypsin inhibitor is crucial to structure and function. Am J Pathol 163, 121-133.
115. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, Strong SA, &, Wight TN, (2004) Intracellular hyaluronan: A new frontier for inflammation? Biochim Biophys Acta 1673, 3-12.
116. Baranova NS, Foulcer SJ, Briggs DC, Tilakaratna V, Enghild JJ, Milner CM, Day AJ, &, Richter RP, (2013) Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking. J Biol Chem 288, 29642-29653.
117. Baranova NS, Nileback E, Haller FM, Briggs DC, Svedhem S, Day AJ, &, Richter RP, (2011) The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J Biol Chem 286, 25675-25686.
118. Hart GW, Housley MP, &, Slawson C, (2007) Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022.
119. Wells L, Vosseller K, &, Hart GW, (2003) A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 60, 222-228.
120. Heickendorff L, Ledet T, &, Rasmussen LM, (1994) Glycosaminoglycans in the human aorta in diabetes mellitus: A study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 37, 286-292.
121. McDonald TO, Gerrity RG, Jen C, Chen HJ, Wark K, Wight TN, Chait A, &, O'Brien KD, (2007) Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem 55, 1149-1157.
122. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, Yamaguchi Y, Rasmussen LM, &, Wogensen L, (2005) Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 96, 583-591.
123. Kashima Y, Takahashi M, Shiba Y, Itano N, Izawa A, Koyama J, Nakayama J, Taniguchi S, Kimata K, &, Ikeda U, (2013) Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One 8, e58760.
124. Reddy MA, &, Natarajan R, (2012) Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 90, 421-429.
125. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, &, Zinman B, (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353, 2643-2653.
126. Ihnat MA, Thorpe JE, &, Ceriello A, (2007) Hypothesis: The 'metabolic memory', the new challenge of diabetes. Diabet Med 24, 582-586.
127. Ceriello A, Ihnat MA, &, Thorpe JE, (2009) The 'metabolic memory': Is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 353, 2643-2653.
128. Johnson JA, Simpson SH, Toth EL, &, Majumdar SR, (2005) Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes. Diabet Med 22, 497-502.